





| 货号 | HB996096 | ||||
|---|---|---|---|---|---|
| 品牌 | abinScience | ||||
| 描述 |
Emfizatamab (HB996096) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation.
Highlights
| ||||
| 种属反应性 | Human | ||||
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo, WB | ||||
| 同种型 | (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa) | ||||
| 表达系统 | Mammalian cells | ||||
| 经测试应用 | WB | ||||
| 靶标 | CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA | ||||
| 内毒素水平 | < 10 EU/mg | ||||
| 纯度 | >95% purity as determined by SDS-PAGE. | ||||
| 纯化方式 | Protein A/G purified from cell culture supernatant. | ||||
| Accession号 | P15391 & Q9NZQ7 & P07766 & Q07011 | ||||
| 状态 | Liquid | ||||
| 保存溶液 | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||
| 产品使用信息 |
| ||||
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||
| 别名 | GNC038, GNC-038, GNC038, 2559704-23-1 | ||||
| 背景 | Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody. | ||||
| Note | For research use only. Not suitable for clinical or therapeutic use. | ||||
| Isotype Control | Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |







24小时产品查询

扫一扫关注我们

专属渠道经理